Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
In one of those situations that makes everyone involved look crazy, Bayer is being taken to task over claiming, in an advertisement for male fertility treatment Menevit, that the quality of New Zealand men's sperm has deteriorated by half in recent years. One complainant said such a thing is impossible to quantify and that Bayer "should not be permitted to make such unsubstantiated and impossible claims." Defensive, much? According to Bayer, the statement was backed by a 20-year study of 975 semen samples, but the country's Advertising Standards Authority found it to be misleading anyway.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in